by Jordana Choucair | Mar 22, 2022 | Life Sciences
Pfizer Inc. said it struck a deal to sell up to 4 million courses of its COVID-19 antiviral pill at a “not-for-profit price” to the United Nations Children’s Fund, which will distribute the treatment to 95 lower-income countries. The drugmaker will...
by Jordana Choucair | Mar 22, 2022 | M&A
Three kidney care providers — Fresenius Health Partners, Cricket Health, and InterWell Health — announced they plan to merge in deal valued at $2.4 billion. The new value-based care company will focus on services for the earlier stages of kidney disease and will...
by Jordana Choucair | Mar 22, 2022 | Opioid/Substance Use Disorders
Allergan and Teva Pharmaceutical reached a $107 million settlement with the state of Rhode Island over their alleged roles in fomenting the U.S. opioid crisis. Under the deal, Teva will pay $21.5 million over 13 years and supply the state with two medicines to combat...
by Jordana Choucair | Mar 22, 2022 | Opioid/Substance Use Disorders
A new RAND Corp. study found that less than a third of patients who were given drugs in emergency departments to treat opioid addiction follow up and continue their treatments. The study examined 92 percent of prescriptions filled at U.S. retail pharmacies before and...
by Jordana Choucair | Mar 22, 2022 | Opioid/Substance Use Disorders
According to a new study published in JAMA, alcohol-related deaths reached record levels during the first year of the COVID-19 pandemic. The number of deaths involving alcohol increased from 78, 927 in 2019 to 99,017 in 2020. Young adults ages 25 to 44 experienced the...
by Jordana Choucair | Mar 21, 2022 | D.C. News
Confirmation hearings for the Supreme Court nominee Judge Ketanji Brown Jackson will kick off later today. Jackson is a former federal public defender who has sat on lower U.S. courts for nearly a decade. Early in her career, she also served as a law clerk to retiring...
Recent Comments